© 2000 by Oxford University Press
Journal of the National Cancer Institute, Vol. 92, No. 14, 1159-1164,
July 19, 2000
© 2000 Oxford University Press
REPORTS |
Familial Risk of Hepatocellular Carcinoma Among Chronic Hepatitis B Carriers and Their Relatives
Affiliations of authors: M.-W. Yu, H.-C. Chang, C.-J. Chen (Graduate Institute of Epidemiology, College of Public Health), C.-J. Liu, P.-J. Chen (Department of Internal Medicine, College of Medicine), P.-H. Lee (Department of Surgery, College of Medicine), National Taiwan University, Taipei; Y.-F. Liaw, S.-M. Lin, Liver Research Unit, Chang-Gung Memorial Hospital, Chang-Gung University, Taipei; S.-D. Lee, Department of Medicine, Veterans General Hospital, Taipei; T.-J. Hsiao, Department of Internal Medicine, Provincial Taoyuan General Hospital, Taiwan.
Correspondence to: Ming-Whei Yu, Ph.D., Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, No. 1 Jen-Ai Rd., Sec. 1, Rm. 1550, Taipei 100, Taiwan (e-mail: mingwhei{at}ha.mc.ntu.edu.tw).
Background: Familial predisposition as a risk factor for hepatocellular carcinoma (HCC) in hepatitis B virus (HBV) carriers has not been thoroughly explored. Methods: The HCC risk associated with having parents and/or siblings with HCC was evaluated by use of a cohort study of 4808 male HBV carriers. A case–control family study was also conducted on data from first-degree relatives of 553 HBV carriers who had newly diagnosed HCC (case subjects) and 4684 HBV carriers without HCC (control subjects). Results: In the cohort study, HBV carriers with a family history of HCC had a multivariate-adjusted rate ratio for HCC of 2.41 (95% confidence interval [CI] = 1.47–3.95) compared with HBV carriers without a family history of HCC. For carriers with two or more affected relatives, the ratio increased to 5.55 (95% CI = 2.02–15.26). Cumulative HCC risk by age 70 years was 235.6 per 1000 (95% CI = 95.3–375.9 per 1000) for HBV carriers with family history compared with 88.9 per 1000 (95% CI = 67.9–109.9 per 1000) for those without. In the case–control family study, first-degree relatives of case subjects were more likely to have HCC (age–sex-adjusted odds ratio [OR] = 2.57; 95% CI = 2.03–3.25) than first-degree relatives of control subjects. The excess risk of HCC among relatives was particularly evident in siblings (sisters—age-adjusted OR = 4.55 [95% CI = 2.22–9.31]; brothers—age-adjusted OR = 3.73 [95% CI = 2.64–5.27]), but it was also observed in parents. The cumulative risk of HCC to age 80 years was 83.0 per 1000 among relatives of case subjects and 42.0 per 1000 among relatives of control subjects. Among relatives of case subjects, the cumulative risk of HCC was greater if the case subjects were diagnosed before age 50 years (two-sided P = .047). Liver cirrhosis was 2.29 (95% CI = 1.68–3.11) times more frequent in relatives of case subjects than in relatives of control subjects. Conclusions: First-degree relatives of patients with HBV-related HCC appear to be at increased risk of HCC and should be considered in the formulation of HCC-screening programs.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M.-W. Yu, W.-L. Shih, C.-L. Lin, C.-J. Liu, J.-W. Jian, K.-S. Tsai, and C.-J. Chen Body-Mass Index and Progression of Hepatitis B: A Population-Based Cohort Study in Men J. Clin. Oncol., December 1, 2008; 26(34): 5576 - 5582. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-W. Wang, S.-L. Pan, Y.-C. Huang, J.-H. Guh, P.-C. Chiang, D.-Y. Huang, S.-C. Kuo, K.-H. Lee, and C.-M. Teng CHM-1, a novel synthetic quinolone with potent and selective antimitotic antitumor activity against human hepatocellular carcinoma in vitro and in vivo Mol. Cancer Ther., February 1, 2008; 7(2): 350 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. D. Shin, B. L. Park, H. S. Cheong, J.-H. Yoon, Y. J. Kim, and H.-S. Lee SPP1 polymorphisms associated with HBV clearance and HCC occurrence Int. J. Epidemiol., October 1, 2007; 36(5): 1001 - 1008. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Pungpapong, W. R. Kim, and J. J. Poterucha Natural History of Hepatitis B Virus Infection: An Update for Clinicians Mayo Clin. Proc., August 1, 2007; 82(8): 967 - 975. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-H. Yeh, D.-C. Wu, C.-Y. Tsai, T.-J. Kuo, W.-C. Yu, Y.-S. Chang, C.-L. Chen, C.-F. Chang, D.-S. Chen, and P.-J. Chen Genetic Characterization of Fas-Associated Phosphatase-1 as a Putative Tumor Suppressor Gene on Chromosome 4q21.3 in Hepatocellular Carcinoma Clin. Cancer Res., February 15, 2006; 12(4): 1097 - 1108. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-W. Yu, S.-H. Yeh, P.-J. Chen, Y.-F. Liaw, C.-L. Lin, C.-J. Liu, W.-L. Shih, J.-H. Kao, D.-S. Chen, and C.-J. Chen Hepatitis B Virus Genotype and DNA Level and Hepatocellular Carcinoma: A Prospective Study in Men J Natl Cancer Inst, February 16, 2005; 97(4): 265 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-W. Yu, S.-Y. Yang, I-J. Pan, C.-L. Lin, C.-J. Liu, Y.-F. Liaw, S.-M. Lin, P.-J. Chen, S.-D. Lee, and C.-J. Chen Polymorphisms in XRCC1 and Glutathione S-Transferase Genes and Hepatitis B-Related Hepatocellular Carcinoma J Natl Cancer Inst, October 1, 2003; 95(19): 1485 - 1488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Chiaverotti and N. R. Drinkwater C57BR/cdJ Hepatocarcinogen Susceptibility Genes Act Cell-Autonomously in C57BR/cdJ{leftrightarrow}C57BL/6J Chimeras Cancer Res., August 15, 2003; 63(16): 4914 - 4919. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Hemminki and X Li Familial liver and gall bladder cancer: a nationwide epidemiological study from Sweden Gut, April 1, 2003; 52(4): 592 - 596. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Szklaruk, P. M. Silverman, and C. Charnsangavej Imaging in the Diagnosis, Staging, Treatment, and Surveillance of Hepatocellular Carcinoma Am. J. Roentgenol., February 1, 2003; 180(2): 441 - 454. [Full Text] [PDF]
|
|
|
|
 |
|
 F.S. Falvella, R. M. Pascale, M. Gariboldi, G. Manenti, M. R. De Miglio, M. M. Simile, T. A. Dragani, and F. Feo Stearoyl-CoA desaturase 1 (Scd1) gene overexpression is associated with genetic predisposition to hepatocarcinogenesis in mice and rats Carcinogenesis, November 1, 2002; 23(11): 1933 - 1936. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-W. Yu, H.-C. Chang, P.-J. Chen, C.-J. Liu, Y.-F. Liaw, S.-M. Lin, S.-D. Lee, S.-C. Lin, C.-L. Lin, and C.-J. Chen Increased risk for hepatitis B-related liver cirrhosis in relatives of patients with hepatocellular carcinoma in northern Taiwan Int. J. Epidemiol., October 1, 2002; 31(5): 1008 - 1015. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Evans, G. Chen, E. A. Ross, F.-M. Shen, W.-Y. Lin, and W. T. London Eight-Year Follow-Up of the 90,000-Person Haimen City Cohort: I. Hepatocellular Carcinoma Mortality, Risk Factors, and Gender Differences Cancer Epidemiol. Biomarkers Prev., April 1, 2002; 11(4): 369 - 376. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-W. Yu, S.-W. Cheng, M.-W. Lin, S.-Y. Yang, Y.-F. Liaw, H.-C. Chang, T.-J. Hsiao, S.-M. Lin, S.-D. Lee, P.-J. Chen, et al. Androgen-Receptor Gene CAG Repeats, Plasma Testosterone Levels, and Risk of Hepatitis B-Related Hepatocellular Carcinoma J Natl Cancer Inst, December 20, 2000; 92(24): 2023 - 2028. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Petersen Familial Aggregation: Sorting Susceptibility From Shared Environment J Natl Cancer Inst, July 19, 2000; 92(14): 1114 - 1115. [Full Text] [PDF]
|
|